Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol , No 15S ( Supplement), :
© 2010 American Society of Clinical Oncology

Return to article

Chemotherapy No. of assays performed Assay NR Assay IR+R 99.9% CI Published population response rates Carboplatin/paclitaxel 332 42% 58% 49–67% 61% Doxorubicin 332 66% 34% 26–43% 10–37% Carboplatin 306 43% 57% 48–66% 24–33% Paclitaxel 303 54% 46% 36–55% 17–77% Docetaxel 272 73% 27% 19–37% 21–31%

Return to article